SOX2 and neoplasm: Various reports suggest that the transcription factor Sox2, a master regulator of embryonic and induced pluripotent stem cells, drives cancer stemness, fuels tumor initiation, and contributes to tumor aggressiveness via major drug resistance mechanisms.